Changes Following Inpatient Child-oriented Family Treatment

This study has been completed.
Sponsor:
Collaborators:
Haukeland University Hospital
St. Olavs Hospital
Levanger Hospital
Namsos Hospital
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00184327
First received: September 13, 2005
Last updated: May 6, 2010
Last verified: January 2009
  Purpose

Children receiving IFT (intensive family therapy) were assessed for symptom profile and global functioning before admission, 3 months after discharge and 1 year after discharge. Children were assessed by parents, children, their teachers and themselves. Parents were assessed by themselves at the same points in time through psychological self-report questionnaires.

The study is intended to explore covariates to change in children as well as in parents during (pre-treatment) the treatment and follow-up periods.


Condition Intervention Phase
Psychiatric Disorders
Behavioral: Intensive family therapy - inpatient
Behavioral: Diagnostic assessment - child and adolescent psychiatry
Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Change Across Intensive Inpatient Family Treatment in Child and Adolescent Psychiatry. A Multi-site Study of Parents and Children in Inpatient Family Treatment

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Enrollment: 150
Study Start Date: January 2002
Study Completion Date: June 2008
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Intensive family therapy - inpatient
    2-4 weeks (5days) family inpatient assessment and treatment
    Behavioral: Diagnostic assessment - child and adolescent psychiatry
Detailed Description:

IFT is an intensive combinatory family treatment which is child-oriented, and traditionally used in an inpatient family treatment unit in child and adolescent psychiatry.

Measures include ones on bonding (PBI), personality traits (NEO-PI), anxiety and depressive symptoms (HADS), attributional tendencies (PAT) and social desirable responding (BIDR). A subgroup was also assessed before a waiting period (pre-treatment).

  Eligibility

Ages Eligible for Study:   6 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Family offered inpatient family treatment in child and adolescent psychiatry

Criteria

Inclusion Criteria:

  • Family offered inpatient family treatment in child and adolescent psychiatry.

Exclusion criteria

  • inpatient treatment terminated prematurely
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184327

Locations
Norway
Haukeland University Hospital, Helse Bergen
Bergen, Norway
Levanger Hospital
Levanger, Norway
Namsos Hospital
Namsos, Norway
Norwegian University of Science and Technology (NTNU), Faculty of Medicine, Dept. of Neuroscience, Center for Child and Adolescent Mental Health
Trondheim, Norway, N-7089
St.Olav Hospital
Trondheim, Norway
Sponsors and Collaborators
Norwegian University of Science and Technology
Haukeland University Hospital
St. Olavs Hospital
Levanger Hospital
Namsos Hospital
Investigators
Principal Investigator: Tormod Rimehaug, Asst. Prof. Norwegian University of Science and Technology (NTNU), Faculty of Medicine, Dept. of Neuroscience, Center for Child and Adolescent Mental Health
  More Information

Additional Information:
No publications provided by Norwegian University of Science and Technology

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: ass professor Tormod Rimehaug, Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184327     History of Changes
Other Study ID Numbers: Forskpro p03000213
Study First Received: September 13, 2005
Last Updated: May 6, 2010
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Severe and longstanding psychiatric symptoms in children

Additional relevant MeSH terms:
Mental Disorders

ClinicalTrials.gov processed this record on July 22, 2014